0000899243-19-005785.txt : 20190304 0000899243-19-005785.hdr.sgml : 20190304 20190304164954 ACCESSION NUMBER: 0000899243-19-005785 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190228 FILED AS OF DATE: 20190304 DATE AS OF CHANGE: 20190304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McIntyre Gail Frances CENTRAL INDEX KEY: 0001492646 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36361 FILM NUMBER: 19654563 MAIL ADDRESS: STREET 1: C/O FURIEX PHARMACEUTICALS, INC. STREET 2: 3900 PARAMOUNT PARKWAY, SUITE 150 CITY: MORRISVILLE STATE: NC ZIP: 27560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aravive, Inc. CENTRAL INDEX KEY: 0001513818 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264106690 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: LYONDELLBASELL TOWER STREET 2: 1221 MCKINNEY STREET, SUITE 3200 CITY: HOUSTON STATE: TX ZIP: 77010 BUSINESS PHONE: 936-355-1910 MAIL ADDRESS: STREET 1: LYONDELLBASELL TOWER STREET 2: 1221 MCKINNEY STREET, SUITE 3200 CITY: HOUSTON STATE: TX ZIP: 77010 FORMER COMPANY: FORMER CONFORMED NAME: Versartis, Inc. DATE OF NAME CHANGE: 20110223 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-28 0 0001513818 Aravive, Inc. ARAV 0001492646 McIntyre Gail Frances C/O ARAVIVE, INC., LYONDELLBASSELL TOWER 1221 MCKINNEY ST., STE 3200 HOUSTON TX 77010 0 1 0 0 Chief Scientific Officer Stock Option 5.83 2019-02-28 4 A 0 53000 0.00 A 2019-03-28 2029-02-27 Common Stock 53000 53000 D These options vest pro rata on a monthly basis over 48 months. /s/ Kevin Haas, Attorney-in-fact 2019-03-04 EX-24.1 2 attachment1.htm EX-24.1 DOCUMENT
                               POWER OF ATTORNEY

    Know all by these presents, that the undersigned hereby constitutes and
appoints each of Kevin Haas and Vinay Shah of Aravive, Inc. (the "Company"),
signing individually, the undersigned's true and lawful attorney-in fact and
agent to:

    (1) prepare, execute on behalf of the undersigned, and submit to the U.S.
        Securities and Exchange Commission (the "SEC") any documents necessary
        or advisable to obtain EDGAR access codes or make any updates to the
        undersigned's EDGAR access codes once obtained, enabling the undersigned
        to make electronic filings of reports with the SEC;

    (2) execute for and on behalf of the undersigned, an officer, director or
        holder of 10% of more of a registered class of securities of the
        Company, Forms 3, 4 and 5 in accordance with Section 16(a) of the
        Securities Exchange Act of 1934, as amended (the "Exchange Act") and the
        rules thereunder;

    (3) do and perform any and all acts for and on behalf of the undersigned
        that may be necessary or desirable to complete and execute such Form 3,
        4 or 5, complete and execute any amendment or amendments thereto, and
        timely file such forms or amendments with the SEC and any stock exchange
        or similar authority; and

    (4) take any other action of any nature whatsoever in connection with the
        foregoing which, in the opinion of such attorney-in-fact, may be of
        benefit, in the best interest of, or legally required by, the
        undersigned, it being understood that the documents executed by such
        attorney-in-fact on behalf of the undersigned pursuant to this Power of
        Attorney shall be in such form and shall contain such terms and
        conditions as such attorney-in-fact may approve in such attorney-in-
        fact's discretion.

    The undersigned hereby grants to such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorney-in-fact, in
serving in such capacity at the request of the undersigned, is not assuming, nor
is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Exchange Act.

        This Power of Attorney shall remain in full force and effect until the
earliest to occur of (a) the undersigned is no longer required to file Forms 3,
4 and 5 with respect to the undersigned's holdings of and transactions in
securities issued by the Company, (b) revocation by the undersigned in a signed
writing delivered to the foregoing attorney-in-fact or (c) until such attorney-
in-fact shall no longer be employed by the Company, as applicable.

        IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 3rd day of March, 2019.

                                        /s/ Gail McIntyre
                                        ----------------------------------------
                                        Gail McIntyre